Evidence-Based Treatment of Repetitive Strain Injuries in Software Engineers

Abstract

For software engineers, repetitive strain can threaten hand endurance and career continuity. This evidence-based review separates true carpal tunnel syndrome from broader upper-extremity strain, examines data for ergonomic modification, wrist splinting, and manual therapy, and evaluates platelet-rich plasma and microfragmented adipose tissue without overstating the science. It explains when surgical referral is appropriate and how integrated chiropractic and medical oversight can protect function while preserving patient choice.

Amazon tech developers, programmers, and data analysts may spend hours moving between keyboards, mice, trackpads, code reviews, and dashboards. When numbness, tingling, thumb weakness, or nighttime hand pain appears, “RSI” is often used as a catch-all label. That is too broad. Repetitive strain injury describes a pattern of load-related complaints, not one diagnosis. Carpal tunnel syndrome, tendinopathy, cervical radiculopathy, ulnar neuropathy, myofascial pain, and joint irritation can overlap, and each requires different management.

Keyboard Exposure Is Not the Same as Proven Carpal Tunnel Causation

Carpal tunnel syndrome occurs when the median nerve is compressed within the carpal tunnel at the wrist. Symptoms commonly involve numbness or tingling in the thumb, index, middle, and part of the ring finger, often worse at night. Advanced disease can produce weakness or thenar muscle loss.

The occupational data are nuanced. A systematic review of prospective cohorts found stronger associations between CTS and high repetition, force intensity, and elevated hand-activity indices, while computer use itself was not shown to increase CTS risk (Hassan et al., 2022). The 2024 American Academy of Orthopedic Surgeons guideline likewise states that reliable evidence does not establish high keyboarding as a cause of CTS (AAOS, 2024).

Intensive computer work is not symptom-neutral. Mouse use, sustained wrist extension, static shoulder loading, and prolonged cervical flexion can aggravate a sensitive upper extremity. For Amazon engineers, the question is not “Did coding cause this condition?” but “Which tissues and nerves are impaired, and which work exposures make symptoms worse?”

Diagnosis Should Precede Treatment

Evidence-based care starts with classification. The AAOS supports the CTS-6 clinical tool, reducing the need for routine electrodiagnostic testing in straightforward cases (AAOS, 2024). Nerve-conduction studies, or electromyography, can be valuable when symptoms are atypical, severe, or progressive, or when another neuropathy is suspected.

A complete examination should assess the neck, shoulder, elbow, forearm, and wrist. Cervical radiculopathy and carpal tunnel syndrome can coexist. In a large surgical database study, CTS occurred more often among patients with cervical radiculopathy than matched controls, although the broader “double-crush” mechanism remains debated (Mills et al., 2024). Wrist treatment alone may fail when proximal neural irritation is present.

Red flags for evaluation include progressive weakness, visible thenar atrophy, persistent sensory loss, major loss of dexterity, or severe electrodiagnostic abnormalities.

What Conservative Care Has the Best Evidence?

For mild to moderate CTS, the 2026 physical therapy clinical practice guideline recommends a forearm-based wrist orthosis that holds the wrist near neutral at night. It also supports ergonomic education, including strategies that reduce provocative mouse use and use keyboards that require less force when keystrokes are painful (Erickson et al., 2026).

A practical plan may include:

• keeping the wrist near neutral instead of extended over a keyboard edge;
• reducing sustained grip pressure on the mouse;
• alternating input devices or mouse hands when practical;
• scheduling movement variability during long coding blocks;
• adjusting monitor and chair position to reduce shoulder loading;
• using symptom-guided tendon or nerve-gliding exercises when clinically appropriate.

The same guideline allows cervical and upper-extremity manual therapy for short-term pain and function improvement in nonsurgically managed mild to moderate CTS (Erickson et al., 2026). A 2024 systematic review also reported improvements in pain, function, symptom severity, and some nerve-conduction measures with manual therapy, although study heterogeneity limits certainty (Cereceda-Muriel et al., 2024).

This supports a measured interpretation of “alignment.” Chiropractic care should not be presented as mechanically pushing a median nerve back into place. Its defensible role is to identify mobility restrictions, reduce relevant mechanical loading, improve cervical and upper-extremity movement, and pair manual treatment with rehabilitation and workplace modification.

PRP: Promising Signals, Important Limits

Platelet-rich plasma concentrates autologous platelets and signaling molecules from the patient’s blood. Several randomized trials have evaluated ultrasound-guided PRP for mild to moderate CTS.

A 2022 meta-analysis of eight randomized trials found improvements in symptoms, function, pain, median-nerve swelling, and selected electrophysiologic outcomes over short or intermediate follow-up (Jiang et al., 2022). A 2025 meta-analysis similarly reported better symptom scores through six months, but objective changes in nerve cross-sectional area and conduction were less consistent (Du et al., 2025).

The 2024 AAOS guideline concluded, with strong evidence, that PRP has not demonstrated long-term benefit in nonoperative CTS management (AAOS, 2024). Therefore, PRP should be framed as an emerging option for selected patients, not a guaranteed nerve-regeneration procedure, a routine substitute for splinting and rehabilitation, or a reason to delay indicated decompression.

MFAT: Biologically Interesting, Not Established CTS Therapy

Microfragmented adipose tissue, or MFAT, is produced from a patient’s own adipose tissue through mechanical processing. It contains a complex cellular and extracellular environment with signaling properties that are being studied across musculoskeletal and chronic pain conditions (D’Souza et al., 2024).

However, enthusiasm must not outrun evidence. Regenerative-medicine guidelines discuss adipose-derived biologics broadly, but high-quality CTS-specific trials supporting MFAT for median-nerve compression remain limited. For software engineers with classic CTS, MFAT should not be marketed as established first-line therapy. Discuss it only after a precise diagnosis, an explanation of evidence gaps, alternatives, cost, regulatory considerations, and realistic expectations.

This is non-maleficence in practice: avoiding both unnecessary surgery and unnecessary biologic intervention.

Surgery Is Not Failure

Conservative care can reduce symptoms and improve function, but it should not become a barrier to timely surgery when nerve damage is progressing. Carpal tunnel release remains a well-established treatment, and AAOS finds mini-open and endoscopic approaches provide similar patient-reported outcomes (AAOS, 2024). Surgical risks include bleeding, infection, wound problems, and nerve aggravation or injury, but modern release procedures are generally effective.

For a developer whose livelihood depends on typing speed, precision, and sustained concentration, career protection means matching treatment intensity to disease severity. Preserving autonomy requires presenting both nonsurgical and surgical pathways fairly.

Integrated Clinical Governance at Injury Medical Clinic PA

Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, combines Doctor of Chiropractic training with board-certified family practice nurse practitioner and advanced practice registered nurse authority. He holds an active Texas Advanced Practice Nursing License #1191402, full Prescriptive Authority #59628, and NPI #1205907805. His clinical scope bridges chiropractic structural assessment, mechanical rehabilitation, functional medicine diagnostics and nutrition, and, when clinically indicated, advanced injection therapies under Dr. Cardenas’s collaborative oversight, including PRP, PRF/PFP, MFAT, ultrasound- or fluoroscopic-guided epidural spinal injections, and bioidentical hormone replacement therapy.

Dr. Maria Guadalupe Cardenas, MD, is board-certified in Internal Medicine with over 40 years of experience as an internist. She holds Texas Medical License #J2933 and NPI #1164426748 and serves as Medical Director, Clinical Director, and collaborative physician alongside Dr. Jimenez at Injury Medical Clinic PA in El Paso. Her role includes internal medicine oversight, advanced laboratory panels including lipids, liver enzymes, and blood chemistry, risk stratification, metabolic comorbidity management, and treatment coordination.

Not every capability belongs in every case. That is the point of multidisciplinary governance: select interventions by diagnosis, evidence, risk, and patient goals rather than by technology availability.

Three Bioethical Tests for Every Treatment Plan

Beneficence means choosing care that improves the patient’s function, sleep, dexterity, and ability to work while addressing mechanical and medical contributors together.

Non-maleficence means beginning with lower-risk, noninvasive strategies when appropriate, avoiding unnecessary medication dependence or procedures, and also avoiding dangerous delays when nerve loss requires surgical consultation.

Autonomy means the engineer receives understandable data, uncertainties, alternatives, and measurable outcomes. The patient remains the decision-maker, and integrative care should coordinate with an existing physician, hand specialist, therapist, or surgical team rather than replace them.

A Data-Driven Path Forward

For Amazon technology professionals, the best RSI strategy isn’t a single treatment. It is a staged system: diagnose accurately, modify aggravating loads, measure response, use evidence-supported conservative care, consider orthobiologics only within their evidence boundaries, and escalate when neurological loss demands it.

If hand symptoms are disrupting sleep, typing accuracy, grip, or concentration, a multidisciplinary evaluation can connect wrist mechanics, cervical function, neurological findings, and medical risk factors into one plan. The goal is not avoiding surgery. It is to protect nerve function, preserve career longevity, and help each patient choose the safest, most effective path with clear evidence.

---

References

American Academy of Orthopaedic Surgeons. (2024). Management of carpal tunnel syndrome: Evidence-based clinical practice guideline. American Academy of Orthopaedic Surgeons.

Cereceda-Muriel, C., Ramírez-Donoso, S., Cárdenas-Caniuqueo, M., Silva-Alfaro, V., & Concha-Valdevenito, D. (2024). Effectiveness of manual therapy in carpal tunnel syndrome: Systematic review and meta-analysis. Cultura, Ciencia y Deporte, 19(59), 145–180.

D’Souza, R. S., Her, Y. F., Hussain, N., Karri, J., Schatman, M. E., Calodney, A. K., et al. (2024). Evidence-based clinical practice guidelines on regenerative medicine treatment for chronic pain: A consensus report from a multispecialty working group. Journal of Pain Research, 17, 2951–3001.

Du, Y., Jiang, X., Fu, K., & Cui, C. (2025). Efficacy and safety of platelet-rich plasma in the treatment of carpal tunnel syndrome: A meta-analysis. Medicine, 104(44), e45010.

Erickson, M., Lawrence, M., Lazinski, M. J., Scott, K., & Martin, R. L. (2026). Hand pain and sensory deficits: Carpal tunnel syndrome: Revision 2026. Journal of Orthopaedic & Sports Physical Therapy, 56(4), CPG1–CPG79.

Hassan, A., Beumer, A., Kuijer, P. P. F. M., & van der Molen, H. F. (2022). Work-relatedness of carpal tunnel syndrome: Systematic review including meta-analysis and GRADE. Health Science Reports, 5(6), e888.

Jiang, J., Xing, F., Luo, R., & Liu, M. (2022). Effectiveness of platelet-rich plasma for patients with carpal tunnel syndrome: A systematic review and meta-analysis of current evidence in randomized controlled trials. Frontiers in Pharmacology, 13, 834213.

Mills, E. S., Mertz, K., Fresquez, Z., Ton, A., Buser, Z., Alluri, R. K., & Hah, R. J. (2024). The incidence of double crush syndrome in surgically treated patients. Global Spine Journal, 14(4), 1220–1226.